Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLY NASDAQ:EYE NASDAQ:NPCE NASDAQ:NVCR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$7.20+1.9%$6.48$1.32▼$9.69$1.80B2.057.70 million shs4.30 million shsEYENational Vision$21.81+5.2%$18.29$14.75▼$30.02$1.66B1.041.70 million shs2.08 million shsNPCENeuroPace$15.31+0.1%$16.10$7.56▼$19.60$521.63M1.88158,408 shs153,839 shsNVCRNovoCure$16.31-4.2%$16.62$9.82▼$21.45$1.98B0.941.83 million shs1.38 million shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network+2.53%+5.51%-18.18%+45.99%+273.21%EYENational Vision+5.16%+10.04%+15.64%-2.59%-10.91%NPCENeuroPace+0.07%-0.97%-7.04%-7.44%+75.17%NVCRNovoCure-4.23%+1.94%+5.70%+36.71%+40.12%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$7.20+1.9%$6.48$1.32▼$9.69$1.80B2.057.70 million shs4.30 million shsEYENational Vision$21.81+5.2%$18.29$14.75▼$30.02$1.66B1.041.70 million shs2.08 million shsNPCENeuroPace$15.31+0.1%$16.10$7.56▼$19.60$521.63M1.88158,408 shs153,839 shsNVCRNovoCure$16.31-4.2%$16.62$9.82▼$21.45$1.98B0.941.83 million shs1.38 million shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network+2.53%+5.51%-18.18%+45.99%+273.21%EYENational Vision+5.16%+10.04%+15.64%-2.59%-10.91%NPCENeuroPace+0.07%-0.97%-7.04%-7.44%+75.17%NVCRNovoCure-4.23%+1.94%+5.70%+36.71%+40.12%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 2.33Hold$5.56-22.78% DownsideEYENational Vision 2.58Moderate Buy$30.0837.93% UpsideNPCENeuroPace 2.89Moderate Buy$19.2925.97% UpsideNVCRNovoCure 2.14Hold$21.2029.98% UpsideCurrent Analyst Ratings BreakdownLatest NPCE, NVCR, BFLY, and EYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/24/2026NVCRNovoCure HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$32.007/24/2026NVCRNovoCure Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold7/24/2026NVCRNovoCure WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$18.00 ➝ $20.007/23/2026NPCENeuroPace MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$22.007/23/2026NVCRNovoCure HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$46.00 ➝ $52.007/14/2026NVCRNovoCure Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell7/13/2026NVCRNovoCure JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$17.006/24/2026NPCENeuroPace Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/18/2026NVCRNovoCure HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$48.00 ➝ $46.006/1/2026NVCRNovoCure Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/15/2026EYENational Vision CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$40.00 ➝ $39.00(Data available from 7/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$97.61M18.79N/AN/A$0.77 per share9.35EYENational Vision$1.99B0.88$1.88 per share11.58$10.96 per share1.99NPCENeuroPace$99.99M5.22N/AN/A$0.57 per share26.86NVCRNovoCure$655.35M2.90N/AN/A$2.90 per share5.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$77.06M-$0.30N/AN/AN/A-73.63%-34.41%-23.91%7/30/2026 (Confirmed)EYENational Vision$29.60M$0.5738.2627.611.812.31%6.41%2.81%8/5/2026 (Estimated)NPCENeuroPace-$21.47M-$0.65N/AN/AN/A-21.67%-108.20%-18.50%8/11/2026 (Estimated)NVCRNovoCure-$136.23M-$1.30N/AN/AN/A-21.25%-44.00%-15.85%N/ALatest NPCE, NVCR, BFLY, and EYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2026Q2 2026NPCENeuroPace-$0.19N/AN/AN/A$22.62 millionN/A8/5/2026Q2 2026EYENational Vision$0.17N/AN/AN/A$499.83 millionN/A7/30/2026Q2 2026BFLYButterfly Network-$0.03N/AN/AN/A$29.16 millionN/A7/23/2026Q2 2026NVCRNovoCure-$0.3315-$0.13+$0.2015-$0.13$172.44 million$183.58 million5/13/2026Q1 2026EYENational Vision$0.43$0.45+$0.02$0.38$545.09 million$543.88 million5/12/2026Q1 2026NPCENeuroPace-$0.19-$0.13+$0.06-$0.20$21.65 million$22.00 million4/30/2026Q1 2026BFLYButterfly Network-$0.04-$0.03+$0.01-$0.05$26.08 million$26.53 million4/30/2026Q1 2026NVCRNovoCure-$0.5122-$0.62-$0.1078-$0.62$167.77 million$174.06 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ANVCRNovoCureN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A4.023.03EYENational Vision0.250.620.37NPCENeuroPace4.085.384.35NVCRNovoCure0.582.892.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%EYENational VisionN/ANPCENeuroPace78.83%NVCRNovoCure84.61%Insider OwnershipCompanyInsider OwnershipBFLYButterfly Network21.99%EYENational Vision2.40%NPCENeuroPace19.20%NVCRNovoCure5.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460254.63 million198.64 millionOptionableEYENational Vision13,13880.12 million78.19 millionOptionableNPCENeuroPace17034.09 million27.55 millionOptionableNVCRNovoCure1,605116.45 million110.02 millionOptionableNPCE, NVCR, BFLY, and EYE HeadlinesRecent News About These CompaniesHealthcare of Ontario Pension Plan Trust Fund Sells 201,000 Shares of NovoCure Limited $NVCR51 minutes ago | marketbeat.comNovoCure (NVCR) Upgraded to Buy: What Does It Mean for the Stock?July 27 at 1:01 PM | zacks.comWall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Here's is How to TradeJuly 27 at 11:03 AM | zacks.comUnlocking NovoCure (NVCR) International Revenues: Trends, Surprises, and ProspectsJuly 27 at 10:29 AM | zacks.comHC Wainwright Predicts NovoCure's Q2 Earnings (NASDAQ:NVCR)July 27 at 1:11 AM | marketbeat.comFY2029 EPS Estimates for NovoCure Reduced by HC WainwrightJuly 26 at 2:32 AM | americanbankingnews.comWedbush Raises NovoCure (NASDAQ:NVCR) Price Target to $20.00July 26 at 1:54 AM | americanbankingnews.comNovoCure (NASDAQ:NVCR) Shares Gap Up Following Earnings BeatJuly 26 at 1:21 AM | americanbankingnews.comNovoCure's strongest quarter ever isn't enough to stop NVCR stock from slidingJuly 25, 2026 | msn.comNovoCure (NVCR) Lifts 2026 Guidance After Record Quarter While Fair Value Debate BuildsJuly 25, 2026 | finance.yahoo.comHC Wainwright Increases NovoCure (NASDAQ:NVCR) Price Target to $52.00July 25, 2026 | americanbankingnews.comNovoCure (NASDAQ:NVCR) Hits New 1-Year High Following Strong EarningsJuly 25, 2026 | americanbankingnews.comNovoCure: Why I'm Fading The Q2 Earnings RallyJuly 24, 2026 | seekingalpha.comNovoCure's Clean Beat Signals A Shift Toward Profitability (Rating Upgrade)July 24, 2026 | seekingalpha.comNovoCure (NASDAQ:NVCR) Shares Gap Up on Strong EarningsJuly 24, 2026 | marketbeat.comNovoCure (NASDAQ:NVCR) Price Target Raised to $20.00 at WedbushJuly 24, 2026 | marketbeat.comFY2029 EPS Estimates for NovoCure Decreased by HC WainwrightJuly 24, 2026 | marketbeat.comNovoCure Limited 2026 Q2 - Results - Earnings Call PresentationJuly 24, 2026 | seekingalpha.comNovocure (NVCR) Hits New High on Optimistic Outlook, FDA Approval HopesJuly 23, 2026 | insidermonkey.comNovoCure surges on Q2 resultsJuly 23, 2026 | en.globes.co.ilENovoCure Limited (NVCR) Q2 2026 Earnings Call TranscriptJuly 23, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNPCE, NVCR, BFLY, and EYE Company DescriptionsButterfly Network NYSE:BFLY$7.20 +0.13 (+1.88%) Closing price 07/28/2026 03:59 PM EasternExtended Trading$7.26 +0.06 (+0.86%) As of 06:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.National Vision NASDAQ:EYE$21.81 +1.07 (+5.16%) Closing price 07/28/2026 04:00 PM EasternExtended Trading$21.81 +0.00 (+0.00%) As of 04:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.NeuroPace NASDAQ:NPCE$15.31 +0.01 (+0.07%) Closing price 07/28/2026 04:00 PM EasternExtended Trading$13.81 -1.50 (-9.80%) As of 04:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.NovoCure NASDAQ:NVCR$16.31 -0.72 (-4.23%) Closing price 07/28/2026 04:00 PM EasternExtended Trading$16.51 +0.20 (+1.23%) As of 04:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas These 3 Stocks Have Soared in 2026—Can They Keep Climbing? Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction Amkor Sells Off After Earnings—Why Weak Guidance Isn't the Real Story Nano Nuclear’s Air Force Contract Puts Its Short-Squeeze Setup in Focus Western Digital’s Earnings Will Test Whether Its AI Rally Has More Room 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys? Is the Market Mispricing ServiceNow's AI Future? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
